NCT06004427 is a NA clinical trial of Diet program in Obesity, sponsored by Uskudar University.

Who is sponsoring NCT06004427?

NCT06004427 is sponsored by Uskudar University.

What drugs are being tested in NCT06004427?

Interventions in NCT06004427: Diet program, Exercise training protocols.

Is NCT06004427 still recruiting?

NCT06004427 is currently completed. Last updated 22 December 2023.

Last reviewed 2023-12-22 · How we verify

NCT06004427

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Investigation of the Effectiveness of Resistance Exercise Program Given With Diet in Obese Individuals.

Completed NA Last updated 22 December 2023

What this trial tests

NA trial testing Diet program in Obesity in 50 participants. Completed in 20 December 2023.

Timeline

1 September 2023

Primary endpoint
30 November 2023

20 December 2023

Quick facts

Lead sponsor	Uskudar University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	1 September 2023
Primary completion	30 November 2023
Estimated completion	20 December 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Diet program
Exercise training protocols

Conditions studied

Obesity — all drugs for Obesity →

Sponsor

Uskudar University

Who can join

Adults 18 to 65, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to examine the effects of diet and combined resistance exercise training on physical activity and sleep patterns compared to diet program alone.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Impact of resistance exercise and diet on physical activity, sleep, and fatigue in obese individuals: a randomized controlled trial.
Buğday B, Çelik AL, Safran EE, Şevgin Ö. · · 2025 · cited 1× · PMID 40604657 · DOI 10.1186/s12889-025-23549-8

Verify or expand the search:

Other trials of Diet program

Trials testing the same drug.

NCT05591794 — Effects of Diet Versus Diet Plus Aerobic and Resistant Exercise Program in Overweight Women · NA · terminated

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other Uskudar University trials

Trials by the same sponsor.

NCT07447193 — Investigation of Pain Perception According to Gender in Individuals With Scoliosis · NA · recruiting
NCT07498088 — THE EFFECT OF HAPTONOMY PRACTICE ON PREGNANT WOMEN WITH A HISTORY OF ABORTION. · NA · not yet recruiting
NCT07447180 — The Effectiveness of Exercise Combined With Ergonomics Training for Musculoskeletal Pain Seen in Pastry Chefs · NA · recruiting
NCT07448467 — Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema. · NA · recruiting
NCT07498114 — Association Between Fatigue Severity and Health-Related Quality of Life in Individuals With Stroke · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06004427 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Uskudar University
Last refreshed: 22 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06004427.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing